PATENT CLAIM ANALYSIS

Application Number: 15934735
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["530", "326000"]

Abstract:
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of non-chronic or chronic inflammatory eye diseases, such as inflammatory diseases of the blephara, conjunctiva, cornea, sclera, the vitreous body, uvea, ciliary body, choroid, orbital bone, lacrimal gland, or iris, in particular wherein the inflammatory disease is selected from hordeolum, chalazion, conjunktivitis, keratitis, scieritis, episcleritis, endophthalmitis, panophtalmitis, irititis, uveitis, cyclitis, chorioiditis, orbital phlegmon, and myositis of the eye muscle etc.

Claim (Index 1):
Use of a JNK inhibitor (poly-)peptide comprising less than 150 amino acids in length for the preparation of a pharmaceutical composition for treating a chronic or non-chronic inflammatory eye disease in a subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.74074
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13879059', '14891067', '15217326', '14640759', '12995192']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.67132586348442
- 35 USC 102 Novelty (BERT): 0.5744192918862517
- Combined Prediction Score: 0.6616352063246032
- Mean Citation Score: 391.125194
- Max Citation Score: 569.8775
- Similarity Product: 361.4447619837523

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test